None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age from 20 years to 50 years Gender : males and/or females Details: It is a placebo controlled two arm study Subject in healthy males and/or females adult, aged 20-50 years on the day of enrolment, subject weight at least 45 kg, subject willing to participate
Exclusion criteria
Exclusion criteria: Subject has any clinically significant illness which is likely to impact to safety for patient or may affect to results of the study Subject has a known hypersensitivity or allergy to quercetin Study subject is participant in other drug trial Study subject unwilling to sign informed consent Study subject is unlikely to complete the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| no adverse effect, performance improvementTimepoint: 1. 0 day, 7 th day and 15th day of the study at 9000 to 12000 ft HA 2. 0 day , 15th day and 30th day of the study at above 12000 ft HA | — |
Secondary
| Measure | Time frame |
|---|---|
| effect of quercetin on Plasma Oxidative stress status and inflammatory markersTimepoint: 2 weeks and 4 weeks | — |
Countries
India
Contacts
DIPAS